Barclays and Bank of America both expect Novo Nordisk's (NYSE: NVO) third-quarter results on November 5 to come broadly in ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Hot List Hot List Pro

Delaware judge does not see current need for court in Metsera bidding war between Pfizer and NovoNovember 4, 2025 11:29 AM Pfizer (PFE) CEO: our bid for Metsera has taken into consideration that prices of GLP-1 will probably start going down - Conference CallNovember 4, 2025 10:49 AM Lilly and Novo near White House deal on obesity drug prices - Endpoints NewsNovember 4, 2025 10:36 AM Novo Nordisk, Pfizer sweeten bid for Metsera as bidding war heats upNovember 4, 2025 9:20 AM Pfizer and Novo Nordisk sweeten offers for Metsera as bidding war intensifies - FTNovember 4, 2025 9:13 AM Metsera declares Novo Nordisk's $10 billion bid superior to Pfizer offerNovember 4, 2025 9:10 AM Metsera Receives Amended Proposal from Novo Nordisk; Metsera Declares Novo Nordisk Amended Proposal "Superior"November 4, 2025 9:09 AM After-hours movers: Palantir, Hims & Hers Health, Sarepta Therapeutics, Sanmina November 3, 2025 4:41 PM Hims & Hers in talks with Novo Nordisk to offer Wegovy treatmentsNovember 3, 2025 4:10 PM Novo Nordisk says Metsera bid won't raise antitrust issuesNovember 3, 2025 12:07 PM Metsera responds to Pfizer litigation amid competing acquisition bidsNovember 3, 2025 11:02 AM Pfizer accuses Novo Nordisk of anticompetitive plot to stall Metsera deal in lawsuitNovember 3, 2025 8:20 AM Pfizer files second lawsuit against Novo Nordisk over Metsera acquisitionNovember 3, 2025 8:16 AM Metsera responds to Pfizer litigation, will address claims in courtNovember 3, 2025 3:53 AM Pfizer sues Metsera directors and Novo Nordisk over merger breachOctober 31, 2025 4:37 PM Pfizer gets early FTC clearance for Metsera acquisitionOctober 31, 2025 3:51 PM